natgillin/translations-raw huggingface dataset:
Fever, coughing, difficulty breathing, wheezing, signs of inflammation of the lung (pneumonia)
Vrućica, kašljanje, otežano disanje, zviždanje pri disanju, znakovi upale pluća (pneumonija)
Fever, coughing, difficulty breathing, wheezing, signs of inflammation of the lung (pneumonitis)
Vrućica, kašljanje, otežano disanje, zviždanje pri disanju, znakovi upale pluća (pneumonitis)
fever, diarrhoea, vomiting.
vrućica, proljev, povraćanje.
fever, easy bruising, frequent infections (signs of blood disorders)
vrućica, laka pojava modrica, česte infekcije (znakovi poremećaja krvi)
Fever, edema*
Vrućica, edem
Fever, edema*
Često
Fever, feeling generally unwell.
vrućica, opće loše osjećanje
fever, flu-like symptoms, night sweats
vrućicu, simptome nalik gripi, noćno znojenje
fever, flu-like symptoms, night sweats
vrućicu, simptome nalik gripi, znojenje noću
Fever, flu-like syndrome (including fatigue, rigors, malaise and flushing)
vrućica, sindrom nalik gripi (uključujući umor, tresavicu, malaksalost i crvenilo uz osjećaj vrućine)
fever, flushing or chills
vrućica, navale crvenila ili zimica
fever, general feeling of being unwell
vrućica, opće loše osjećanje
fever, general pain, discomfort, tiredness, feeling hot, malaise, flu-like illness
vrućica, generalizirani bol, nelagoda, umor, osjećaj vrućine, slabost, bolest nalik gripi
fever, general weakness, chills
groznica, opća slabost, zimica
fever, headache, vomiting and drowsiness progressing to coma or fits (convulsions) which are symptoms of an inflammation of the brain and spinal cord weakness beginning in the legs and progressing to the arms with numbness and tingling sensation which are symptoms of an inflammation of the nerves
vrućica, glavobolja, povraćanje i omamljenost koji se razvijaju do kome ili napadaja (konvulzija), koji su simptomi upale mozga i leđne moždine slabost počinje u nogama i napreduje do ruku uz utrnulost i osjećaj trnaca, što su simptomi upale živaca
Fever, increased sweating
vrućica, pojačano znojenje
fever, often with other signs of infection due to decreased number of white blood cells
vrućica, često s drugim znacima infekcije, povezano s padom broja bijelih krvnih stanica
fever, or if you seem to be catching a lot of infections.
vrućica, ili ako Vam se čini da često imate infekcije.
fever, severe headache that does not go away.
vrućicu, jaku glavobolju koja ne prestaje.
fever, shaking/shivering, weakness, tiredness or general discomfort
vrućica, tresavica/drhtanje, slabost, umor, opća nelagoda
Fever, shivering, generally feeling unwell
Vrućica, tresavica, općenito loše osjećanje
Fever, skin rash, joint pain and inflammation, as well as tiredness, loss of appetite, nausea, jaundice (yellowing of the skin), pain in the upper right abdomen, pale stools, dark urine (may be signs of hepatitis B reactivation)
Vrućica, osip na koži, bol i upala u zglobovima, kao i umor, gubitak apetita, mučnina, žutica (žutilo kože), bol u gornjem desnom dijelu trbuha, blijeda stolica, tamna mokraća (mogu biti znakovi reaktivacije hepatitisa B)
Fever, sore throat or mouth ulcers due to infections, sign of low level of white blood cells (leucopenia, lymphopenia, neutropenia)
Vrućica, grlobolja ili ranice u ustima zbog infekcija, znakovi niske razine bijelih krvnih stanica (leukopenija, limfopenija, neutropenija)
fever, sore throat or mouth ulcers, more frequent infections (lack or low level of white blood cells)
vrućica, grlobolja ili čirevi u ustima, učestalije infekcije (manjak ili niska razina bijelih krvnih stanica)
Fever, sore throat or mouth ulcers, more frequent infections (lack or low level of white blood cells)
vrućica, grlobolja ili čirevi u ustima, češće infekcije (manjak ili niska razina bijelih krvnih stanica)
Fever, sore throat, cough, or any other signs of infection (due to reduced number of white blood cells, which fight infection).
vrućicu, bol u grlu, kašalj ili bilo koje druge znakove infekcije (zbog sniženog broja bijelih krvnih stanica koje brane organizam od infekcije)
Fever, sore throat, mouth ulcers due to infections (signs of low level of white blood cells, leukopenia, lymphopenia and/or neutropenia)
Vrućica, grlobolja, ranice u ustima zbog infekcija (znakovi niske razine bijelih krvnih stanica; leukopenija, limfopenija i/ili neutropenija)
Fever, sweating, muscle stiffness, and reduced consciousness.
vrućica, znojenje, ukočenost mišića, smanjena svijest.
fever, swelling in the limbs, feeling ill problems with liver function (seen in blood tests) and increased blood bilirubin (excreted by the liver)
vrućica, oticanje udova, osjećaj bolesti problemi s funkcijom jetre (kao što pokazuju krvne pretrage) i povišene razine bilirubina u krvi (izlučuje ga jetra)
fever, swelling in the limbs, feeling ill problems with liver function (seen in blood tests) and increased blood bilirubin (excreted by the liver)
vrućica, oticanje udova, osjećaj da ste bolesni problemi s funkcijom jetre (na rezultatima nalaza krvi) i povišen bilirubin u krvi (koji se izlučuje iz jetre)
fever, swelling in the limbs, feeling ill problems with liver function (seen in blood tests) and increased blood bilirubin (excreted by the liver)
vrućica, oticanje udova, osjećaj da ste bolesni problemi s radom jetre (vide se iz nalaza krvnih pretraga) i povišeni bilirubin (tvar koju luči jetra) u krvi
fever, swelling in the limbs, feeling ill problems with liver function (seen in blood tests) and increased blood bilirubin (excreted by the liver).
vrućica, oticanje udova, osjećaj da ste bolesni problemi s radom jetre (vide se iz nalaza krvnih pretraga) i povišeni bilirubin (tvar koju luči jetra) u krvi.
fever, swelling of hands, feet or face, fatigue, weakness.
vrućica, oticanje ruku, stopala ili lica, umor, slabost;
fever, swelling of lower limbs due to fluids, malaise, irritability, pain
vrućica, oticanje nogu zbog nakupljanja tekućine, opća slabost, razdražljivost, bol
fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may be severe and can be fatal (cytokine storm), allergic reaction
vrućica, oticanje, zimica, snižen ili povišen krvni tlak i tekućina u plućima, što može postati teško stanje i imati smrtan ishod (citokinska oluja), alergijska reakcija
fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may become severe (cytokine release syndrome)
vrućica, oticanje, zimica, snižen ili povišen krvni tlak i tekućina u plućima, što može postati teško stanje (sindrom otpuštanja citokina)
fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may become severe – these may be signs of a so-called cytokine release syndrome. if you have severe and persistent stomach pain, with or without nausea and vomiting, as these may be symptoms of a serious and potentially fatal condition known as pancreatitis (inflammation of the pancreas).
vrućica, oticanje, zimica, snižen ili povišen krvni tlak i tekućina u plućima, što može postati teško stanje – ovo mogu biti znakovi takozvanog sindroma otpuštanja citokina. ako imate tešku i trajnu bol u trbuhu, sa ili bez mučnine i povraćanja, jer to mogu biti simptomi ozbiljnog stanja s mogućim smrtnim ishodom poznatog kao pankreatitis (upala gušterače).
fever, vomiting and abdominal pain or discomfort (diverticulitis), ear infection.
vrućica, povraćanje i bol u trbuhu te nelagoda u trbuhu (divertikulitis), infekcija uha.
Fever, weakness (asthenia),
vrućica, slabost (astenija),
fever, weakness, fatigue (tiredness) a reaction at the injection site, including itching, pain or swelling
vrućica, slabost, umor reakcija na mjestu injekcije, uključujući svrbež, bol ili oticanje
fever, weakness, fatigue (tiredness) a reaction at the injection site, including itching, pain or swelling.
vrućica, slabost, umor reakcija na mjestu primjene injekcije, uključujući svrbež, bol ili oticanje
Fever, with a racing heart beat, rapid shallow breathing, cold, pale, clammy or mottled skin and/or confusion.
vrućica uz ubrzane otkucaje srca, brzo i plitko disanje, hladna, blijeda, vlažna koža ili koža s mrljama promijenjene boje, i/ili smetenost.
Fever.
vrućica
Fever.
vrućica.
fever/body temperature increased
vrućicu/povišenu tjelesnu temperaturu
fever: if this happens you must tell your doctor immediately
vrućica: ako imate povišenu temperaturu odmah obavijestite svog liječnika
fever: if this happens you must tell your doctor immediately
vrućica: ako se to dogodi odmah obavijestite svog liječnika
Fever: if you have a temperature of 38°C or greater.
Vrućica: ako imate temperaturu od 38°C ili višu.
Fever: this may be a sign of an infection caused by low levels of white blood cells (very common). chest pain or shortness of breath (with or without fever or cough): these may be signs of an infection of the lung called “pneumonia” (very common).
Vrućica: to može biti znak infekcije prouzročene malim brojem bijelih krvnih stanica (vrlo često). bol u prsima ili nedostatak daha (sa ili bez vrućice ili kašlja): to mogu biti znakovi infekcije pluća koja se naziva “upala pluća” (vrlo često).
fever;
vrućica,
fever;
vrućica;
FeverA, peripheral oedema, decreased general strength and energy (incl. fatigue and asthenia)
VrućicaA, periferni edem, smanjenje opće snage i energije (uklj. umor i asteniju)
FeverA, peripheral oedema, decreased general strength and energy (incl. fatigue and asthenia)
VrućicaA, periferni edem, smanjenje opće snage i energije (uključujući umor i asteniju)
Few ACS patients with a prior stroke or TIA have been studied but the limited efficacy data available indicate that these patients do not benefit from treatment.
Ispitana je nekolicina bolesnika s akutnim koronarnim sindromom koji su imali moždani udar ili TIA, ali ograničeni podaci o djelotvornosti koji su dostupni pokazuju da ovi bolesnici nemaju koristi od ovog liječenja.
Few adverse reactions are known to be directly attributable to the active substance entacapone including diarrhoea and reddish- brown discolouration of urine.
Mali broj nuspojava za koje se zna da su direktno pripisive djelatnoj tvari entakaponu obuhvaća proljev i crvenkasto-smeđu diskoloraciju mokraće.
Few cases (0.05%) of angioedema have been reported during all long­term clinical trials with Victoza.
Tijekom svih dugotrajnih kliničkih ispitivanja lijeka Victoza prijavljeno je nekoliko (0,05%) slučajeva angioedema.
Few cases (<0.2%) of acute pancreatitis have been reported during long­term clinical trials with Victoza.
Tijekom dugotrajnih kliničkih ispitivanja lijeka Victoza prijavljeno je nekoliko slučajeva (<0,2%) akutnog pankreatitisa.
Few patients discontinued treatment due to injections site reactions, see section 4.8.
Malo je bolesnika prekinulo liječenje zbog reakcija na mjestu primjene.
Few patients were treated during the study because congenital antithrombin deficiency is rare - it is estimated that only about one person in 3,000 to 5,000 has the condition.
U okviru ispitivanja liječeno je malo bolesnika jer je urođeni nedostatak antitrombina rijetka bolest.
Few pre-clinical data are available with respect to reproductive toxicity (see section 5.3).
Dostupno je nekoliko pretkliničkih podataka o reproduktivnoj toksičnosti (vidjeti dio 5.3).
fewer cases
(3,9; 56,0)
fewer cases than
manje slučajeva
fewer cases than injectable
manje slučajeva nego s cjepivom koje se injicira
Fewer red blood cells or less haemoglobin than normal;
Manji broj crvenih krvnih stanica ili manje hemoglobina nego što je normalno;
Fewer subjects underwent colectomy in the 5 mg/kg infliximab group (28/242 or 11.6% [N.S.]) and the
Kolektomiji je podvrgnut manji broj bolesnika koji su primali infliksimab u dozama od
Fexeric 1 g (carton only)
Fexeric 1 g (samo na kutiji)
Fexeric 1 g film-coated tablets ferric citrate coordination complex
Fexeric 1 g filmom obložene tablete kompleksni spoj željezovog citrata
Fexeric contains ferric citrate coordination complex as the active ingredient.
Djelatna tvar Fexerica je kompleksni spoj željezovog citrata.
Fexeric contains iron and your doctor may need to adjust the dose of your other iron-containing medicines. aluminium containing medicines
Fexeric sadrži željezo te će Vaš liječnik možda trebati prilagoditi dozu Vaših drugih lijekova koji sadrže željezo. lijekovi koji sadrže aluminij
Fexeric ferric citrate coordination complex
Fexeric koordinacijski kompleks željezovog citrata
Fexeric has no influence on your ability to drive and use machines.
Fexeric ne utječe na sposobnost upravljanja vozilima i rada sa strojevima.
Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).
Fexeric je indiciran za kontrolu hiperfosfatemije u odraslih bolesnika s kroničnom bolesti bubrega (KBB).
Fexeric is not recommended during pregnancy and in women of childbearing potential not using contraceptive methods.
Ne preporučuje se uzimanje Fexerica tijekom trudnoće niti ženama u reproduktivnoj dobi koje ne koriste kontracepciju.
Fexeric should be temporarily discontinued if serum ferritin exceeds 800 ng/ml (see section 4.4).
Ako feritin u serumu prelazi 800 ng/ml, primjenu Fexerica treba privremeno prekinuti (vidjeti dio 4.4).
Fexeric should not be taken at the same time as aluminium containing medicines.
Fexeric se ne smije uzimati istodobno s lijekovima koji sadrže aluminij.
Fexofenadine
feksofenadi
fexofenadine
lumakaftor/ivakaftor.
Fexofenadine Ritonavir may modify P-glycoprotein mediated fexofenadine efflux when dosed as an antriretroviral agent or as a pharmacokinetic enhancer resulting in increased concentrations of fexofenadine.
Feksofenadin Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač može modificirati istjecanje feksofenadina posredovan P- glikoproteinom, zbog čega će se povećati koncentracije feksofenadina.
Fexofenadine Ritonavir may modify P-glycoprotein mediated fexofenadine efflux when dosed as an antriretroviral agent or as a pharmacokinetic enhancer resulting in increased concentrations of fexofenadine.
Feksofenadin Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač može modificirati istjecanje feksofenadina posredovan P-glikoproteinom, zbog čega će se povećati koncentracije feksofenadina.
FFC = Fixed flexion contracture ROM = Range of motion
FFC = fiksna fleksijska kontraktura ROM = raspon pokreta
FHV (F2 strain) .................................................................................................................  104.9 CCID50
FHV (soj F2) ....................................................................................................................  104,9 CCID50
FHV (F2 strain) .................................................................................................................  104.9 CCID50
FHV (soj F2) .....................................................................................................................  104,.9 CCID50
FHV (F2 strain) .................................................................................................................  104.9 CCID50
FHV (soj F2) .....................................................................................................................  104,9 CCID50
FI-02200 Espoo
FI-02200 Espoo Finska
FI.PT@gsk.com
Tel:++385 1 6051 999
fibrates (used to lower high levels of blood lipids), monoamine oxidase (MAO) inhibitors (used to treat depression),
fibrate (koriste se za snižavanje visoke razine masnoća u krvi) inhibitore monoaminooksidaze (MAO inhibitore) (koriste se za liječenje depresije)
fibrates (used to lower high levels of blood lipids), monoamine oxidase (MAO) inhibitors (used to treat depression),
fibrate (koriste se za snižavanje visoke razine masnoća u krvi), inhibitore monoaminooksidaze (MAO inhibitore) (koriste se za liječenje depresije),
fibrates (used to lower high levels of blood lipids), monoamine oxidase (MAO) inhibitors (used to treat depression),
fibrate (koriste se za snižavanje visokih razina masnoća u krvi) inhibitore monoamino-oksidaze (MAO inhibitore) (koriste se za liječenje depresije),
fibrates (used to lower high levels of blood lipids), monoamine oxidase (MAO) inhibitors (used to treat depression),
fibrate (koriste se za snižavanje visokih razina masnoća u krvi), inhibitore monoamino-oksidaze (MAO inhibitore) (koriste se za liječenje depresije),
Fibrates – for lowering high levels of blood fats.
fibrate – koriste se za snižavanje visoke razine masnoća u krvi
fibrillation (rare), QT
ventrikula (rijetko),
fibrillation,
pointes
fibrillatione, supraventricular tachycardiae
ajuće besmislene radnje, prejedanje/poreme
fibrillatione, supraventricular tachycardiae
ajuće besmislene radnje, prejedanje/poremeć
Fibrin D-dimer increased
Povišeni fibrinski D-dimeri
Fibrin glues are routinely used in ACI procedures to seal the outside margins and to improve the water-tightness of the compartment of the biological membrane used to cover the defect.
Fibrinska ljepila rutinski se upotrebljavaju u ACI postupcima za zatvaranje vanjskih rubova i za poboljšavanje vodonepropusnosti odjeljka biološke membrane koja se koristi za prekrivanje oštećenja.
Fibrin Sealants/haemostatics are metabolised in the same way as endogenous fibrin by fibrinolysis and phagocytosis.
Fibrinska tkivna ljepila/hemostatici se metaboliziraju na isti način kao endogeni fibrin, fibrinolizom i fagocitozom.
Fibrinogen and thrombin are packaged together as two vials each containing the same volume (1ml, 2ml, or 5ml) of frozen, sterile solution, which is colourless or yellowish when thawed.
Fibrinogen i trombin pakirani su zajedno kao dvije bočice od kojih svaka sadrži jednak volumen (1 ml, 2 ml ili 5 ml) smrznute sterilne otopine koja je nakon odmrzavanja bezbojna ili žućkasta.
Fibrinogen and thrombin are stable at room temperature for 24 hours but when they have been drawn up into the administration device, they must be used immediately.
Fibrinogen i trombin su stabilni na sobnoj temperaturi tijekom 24 sata, ali nakon što se navuku u aplikator, moraju se odmah upotrijebiti.
Fibrinogen can be regarded as a parameter of the pro- and anticoagulatory system.
Fibrinogen se može smatrati parametrom prokoagulacijskog i antikoagulacijskog sustava.
Fibrinogen is a concentrate of clottable protein and thrombin is an enzyme that causes clottable protein to coalesce.
Fibrinogen je koncentrat proteina sa sposobnošću zgrušavanja, a trombin je enzim koji uzrokuje sljepljivanje proteina sa sposobnošću zgrušavanja.
Fibroblastic (adult fibrosarcoma, myxofibrosarcoma, sclerosing epithelioid fibrosarcoma, malignant solitary fibrous tumours), so-called fibrohistiocytic (pleomorphic malignant fibrous histiocytoma [MFH], giant cell MFH, inflammatory MFH), leiomyosarcoma, malignant glomus tumours, skeletal muscles (pleomorphic and alveolar rhabdomyosarcoma), vascular (epithelioid hemangioendothelioma, angiosarcoma), uncertain differentiation (synovial, epithelioid, alveolar soft part, clear cell, desmoplastic small round cell, extra-renal rhabdoid, malignant mesenchymoma, PEComa, intimal sarcoma), malignant peripheral nerve sheath tumours, undifferentiated soft tissue sarcomas not otherwise specified (NOS) and other types of sarcoma (not listed as ineligible).
Fibroblastični (fibrosarkom odraslih, miksofibrosarkom, sklerozirajući epiteloidni fibrosarkom, maligni solitarni fibrozni tumori), takozvani fibrohistiocitni (pleomorfni maligni fibrozni histiocitom [MFH], MFH velikih stanica, inflamatorni MFH), leiomiosarkom, maligni glomus tumor, skeletni mišići (pleomorfni i alveolarni rabdomiosarkom), krvožilni (epiteloidni hemangioendoteliom, angiosarkom), nesigurne diferencijacije (sinovijalni, epiteloidni, alveolari mekotkivni, svijetlih stanica, dezmoplastičnih okruglih malih stanica, ekstra renalni rabdoidni, maligni mezenhimom, PECom, sarkom intime), maligni tumori ovojnice perifernih živaca, nediferencirani sarkomi mekih tkiva koji nisu drugačije specificirani (NOS) i drugi tipovi sarkoma (nisu navedeni kao nepogodni).
Fibroid tumours of the uterus incompatible with pregnancy
Fibroidni tumori maternice nespojivi s trudnoćom
fibroid tumours of the uterus incompatible with pregnancy primary testicular insufficiency
fibroidni tumori maternice nespojivi s trudnoćom primarna insuficijencija testisa
Fibroid tumours of the uterus incompatible with pregnancy.
Fibroidni tumori maternice nespojivi s trudnoćom.
Fibroid tumours of the uterus incompatible with pregnancy.
Fibroidni tumori uterusa nespojivi s trudnoćom.
fibroid tumours of the uterus incompatible with pregnancy; primary testicular insufficiency.
fibroidni tumori maternice nespojivi s trudnoćom primarna insuficijencija testisa.
fibroid tumours of the uterus incompatible with pregnancy; primary testicular insufficiency.
fibroidnih tumora maternice nespojivih s trudnoćom; primarne testikularne insuficijencije.
Fibroids in the womb (uterus)
fibroidi u maternici (uterusu)
fibroids inside your womb
fibroidi unutar maternice
Fibrosing colonopathy** Lip swelling and swollen tongue*
oticanje usana i oticanje jezika
Fibrosis score
rezultat fibroze
Fibrosis stage
Stadij fibroze
FibroTest-Determined Metavir scoreb
Metavir rezultat određen FibroTestomb
FibroTest-Determined Metavir scoreb
Metavir-rezultat određen FibroTestomb
Fidaxomicin and the metabolite OP-1118 are substrates of P-gp.
Fidaksomicin i metabolit OP-1118 supstrati su P-gp.
Fidaxomicin should be used with caution in these patients due to the risk of enhanced absorption and potential risk of systemic adverse reactions.
U tih bolesnika fidaksomicin treba primjenjivati s oprezom zbog rizika od pojačane apsorpcije i mogućeg rizika od sistemskih nuspojava.
Field cancerization is characterised by an area of skin where multiple AK lesions are present and there is likely to be an underlying and surrounding area of actinic damage (a concept known as field cancerization or field change); the extent of this area may not be evident visually or by physical examination.
Područje zloćudne transformacije karakterizirano je područjem kože na kojem je prisutno više lezija aktiničke keratoze ispod i oko kojih vjerojatno postoji područje aktiničkog oštećenja (pojam koji znači područje zloćudne transformacija ili područje promjena); veličina ovog područja ne može se uvijek odrediti vizualnim ili fizikalnim pregledom.
field defect, Diplopia,
zamagljeni vid
Field recalcitrantc
Otpornost u područjuc
Field recurrentd
Povrat u područjud
Field strengths from fixed RF transmitters, as determined by an electromagnetic site survey, a should be less than the compliance level in each frequency range. b
Snage polja stacionarnih RF odašiljača, određene elektromagnetskim mjerenjem na lokaciji a, trebale bi biti manje od razine sukladnosti u svakom frekvencijskom rasponu. b
Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio, AM and FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy.
Snage polja stacionarnih RF odašiljača, poput baznih stanica za radiotelefoniju (mobilnu/bežičnu) i zemaljskih mobilnih radio sustava, AM i FM radijskih odašiljača i televizijskih odašiljača, ne mogu se teoretski precizno predvidjeti.
Field studies involving heartworm in dogs were conducted both in the USA and Europe.
Terenska ispitivanja, uključujući srčanog crva u pasa, provedena su i u Europi i u SAD-u.
Fifteen children between the age of 6 to less than 18 years old and six children less than 6 years old have been treated with NovoThirteen for a total of 393 exposures.
Petnaestero djece u dobi od 6 do manje od 18 godina i šestero djece mlađih od 6 godina liječeno je lijekom NovoThirteen za ukupno 393 izlaganja.
Fifteen hundred sixty five (1565) subjects received single or multiple doses of intravenous anidulafungin in clinical trials: 1308 in Phase 2/3 trials (923 patients with candidaemia/invasive candidiasis, 355 patients with oral/oesophageal candidiasis, 30 patients with invasive aspergillosis), and 257 in Phase I studies.
Tisuću pet stotina šezdeset i pet (1565) ispitanika u kliničkim je ispitivanjima intravenski primilo jednu ili više doza anidulafungina: 1308 u ispitivanjima faze 2/3 (923 bolesnika s kandidemijom/invazivnom kandidijazom, 355 bolesnika s oralnom/ezofagealnom kandidijazom, 30 bolesnika s invazivnom aspergilozom) i 257 u ispitivanjima faze I.